dbl® potassium dihydrogen phosphate & dipotassium hydogen phosphate
pfizer new zealand limited - dibasic potassium phosphate 54 mg/ml; monobasic potassium phosphate 183 mg/ml - solution for injection - active: dibasic potassium phosphate 54 mg/ml monobasic potassium phosphate 183 mg/ml
dbl potassium phosphate
pfizer australia pty ltd - dibasic potassium phosphate, quantity: 183 mg/ml; monobasic potassium phosphate, quantity: 54 mg/ml - injection, concentrated - excipient ingredients: water for injections - indications as at 24 march 2004: treatment of severe hypophosphataemia (serum levels less than 0.3 mmol/l) and other degrees of hypophosphataemia when oral therapy is not possible. the cause of hypophosphataemia should be identified and treated.
potassium phosphates- potassium phosphate, monobasic and potassium phosphate, dibasic injection, solution
fresenius kabi usa, llc - potassium phosphate, monobasic (unii: 4j9fj0hl51) (phosphate ion - unii:nk08v8k8hr), potassium phosphate, dibasic (unii: ci71s98n1z) (phosphate ion - unii:nk08v8k8hr) - potassium phosphate, monobasic 224 mg in 1 ml - potassium phosphates injection, usp is indicated as a source of phosphate, for addition to large volume intravenous fluids to prevent or correct hypophosphatemia in patients with restricted or no oral intake. it is also useful as an additive for preparing specific intravenous fluid formulas when the needs of the patient cannot be met by standard electrolyte of nutrient solutions. potassium phosphates is contraindicated in diseases where high potassium, high phosphate or low calcium levels may be encountered.
potassium phosphates- potassium phosphate, monobasic and potassium phosphate, dibasic injection, solution, concentrate
hospira, inc. - monobasic potassium phosphate (unii: 4j9fj0hl51) (potassium cation - unii:295o53k152, phosphate ion - unii:nk08v8k8hr), dibasic potassium phosphate (unii: ci71s98n1z) (phosphate ion - unii:nk08v8k8hr, potassium cation - unii:295o53k152) - potassium phosphate, monobasic 224 mg in 1 ml - potassium phosphates injection, usp, 3 mm p/ml is indicated as a source of phosphorus, for addition to large volume intravenous fluids, to prevent or correct hypophosphatemia in patients with restricted or no oral intake. it is also useful as an additive for preparing specific intravenous fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions. the concomitant amount of potassium (k+ 4.4 meq/ml) must be calculated into total electrolyte dose of such prepared solutions. safety has not been established for parenteral nutrition in pediatric patients due to the risk of aluminum toxicity. (see warnings) potassium phosphate is contraindicated in diseases where high potassium, high phosphorus or low calcium levels may be encountered.
potassium phosphates injection, usp solution
fresenius kabi canada ltd - potassium phosphate monobasic; potassium phosphate dibasic - solution - 224mg; 236mg - potassium phosphate monobasic 224mg; potassium phosphate dibasic 236mg - replacement preparations
monobasic sodium phosphate and dibasic sodium phosphate tablet
novel laboratories, inc. - sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (sodium cation - unii:lyr4m0nh37), sodium phosphate, dibasic anhydrous (unii: 22ado53m6f) (sodium cation - unii:lyr4m0nh37) - sodium phosphate, monobasic, monohydrate 1.105 g - monobasic sodium phosphate and dibasic sodium phosphate tablets are indicated for cleansing of the colon as a preparation for colonoscopy in adults 18 years of age or older. monobasic sodium phosphate and dibasic sodium phosphate tablets are contraindicated in patients with biopsy-proven acute phosphate nephropathy. monobasic sodium phosphate and dibasic sodium phosphate tablets are contraindicated in patients with a known allergy or hypersensitivity to sodium phosphate salts or any of its ingredients. laxatives and purgatives (including monobasic sodium phosphate and dibasic sodium phosphate tablets) have the potential for abuse by bulimia nervosa patients who frequently have binge eating and vomiting.
potassium phosphate 6 tablet
biocentre - potassium phosphate dibasic - tablet - 6x - potassium phosphate dibasic 6x - homeopathic products
potassium phosphates liquid
sandoz canada incorporated - potassium phosphate monobasic; potassium phosphate dibasic - liquid - 224mg; 236mg - potassium phosphate monobasic 224mg; potassium phosphate dibasic 236mg - replacement preparations
potassium phosphates inj liquid
lyphomed, division of fujisawa canada inc. - potassium phosphate monobasic; potassium phosphate dibasic - liquid - 224mg; 236mg - potassium phosphate monobasic 224mg; potassium phosphate dibasic 236mg - replacement preparations
potassium phosphate dibasic liquid (s#168)
total health centre - potassium phosphate dibasic - liquid - 1x - potassium phosphate dibasic 1x - homeopathic products